Sanofi SA at Morgan Stanley Healthcare Conference Transcript
Okay. Good morning, everyone. My name is Mark Purcell. I'm the European pharmaceutical analyst here at Morgan Stanley. It gives me great pleasure to introduce John Reed, who's the Executive Vice President, Global Head of Research and Development at Sanofi.
Before I start, I just want to highlight important disclosures and refer to Morgan Stanley website on the research portal for you to read on -- in that respect.
Questions & Answers
I guess you've been at Sanofi for a while now. And John, if you could help us understand what you've been doing since you took the helm and some of the perspectives of your R&D role at Sanofi. Obviously, you came from a competitor where you, from my impression, it was a sort of patient capital way of building a very exciting early stage pipeline around some platforms around some neuroscience assets. There were some in-licensing deals in there as well, but it'd be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
